Product Code: GVR-4-68040-100-0
Peripheral Vascular Stents Market Growth & Trends
The global peripheral vascular stents market size is expected to reach USD 2.97 billion by 2030, growing at 7.4% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. The market's growth can be attributed to the increasing prevalence of peripheral vascular diseases (PVDs). According to the American Heart Association (AHA) and their Heart Disease and Stroke Statistics - 2022 Update, cardiovascular disease (CVD) was the primary cause of approximately 19.05 million deaths worldwide in 2020. In addition, cerebrovascular diseases were responsible for around 7.08 million deaths globally during the same year. These alarming statistics highlight the significant burden of cardiac diseases and underscore the need for effective interventions such as peripheral vascular stents.
The market growth is further propelled by technological advancements and the continued approval of new products, supported by partnerships and collaborations among key industry players. For instance, Cordis, a renowned cardiovascular technology company, obtained approval from the United States Food and Drug Administration (FDA) in March 2022 for the S.M.A.R.T. RADIANZ Vascular Stent System. This self-expanding stent is specifically designed for radial peripheral procedures. The recently approved BRITE TIP RADIANZ Guiding Sheath and SABERX RADIANZ PTA Catheter complement this system. These innovative solutions optimize radial access, deliver remarkable outcomes, and enhance patient satisfaction.
Peripheral Vascular Stents Market Report Highlights
- In 2022, the drug-eluting stents (DES) segment accounted for the largest share of 60.52% of the market. DES effectively reduces restenosis compared to bare metal stents (BMS). They also lower the incidence of major adverse cardiac events (MACE)
- In 2022, the balloon-expanding stents segment accounted for the largest share of 53.92% of the market. Balloon-expanding stents provide a notable advantage by allowing precise and controlled expansion within the affected blood vessel. Furthermore, the increasing preference for minimally invasive procedures has greatly contributed to the growth of this segment
- In 2022, the Iliac artery stents segment accounted for the largest share of 33.46% of the market. Iliac arterial occlusive disease affects many individuals, including around 8 million people in the U.S.
- In 2022, the hospital & cardiac centers segment accounted for the largest share of 74.54% of the market. Hospital and cardiac centers are essential in diagnosing and treating CVDs, including conditions related to peripheral arterial disease
- In 2022, North America accounted for the largest share of 43.79% of the market. North America is home to a robust healthcare infrastructure with advanced medical facilities and skilled healthcare professionals, ensuring easy access to peripheral vascular stents for patients in the region
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definitions
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Sources & Third - Party Perspectives
- 1.3.4. Primary Research
- 1.3.5. Details of Primary Research
- 1.4. Information Analysis
- 1.4.1. Data Analysis Models
- 1.5. Market Formulation & Data Visualization
- 1.5.1. Commodity Flow Analysis
- 1.5.1.1. Approach 1: Commodity flow approach
- 1.6. Data Validation & Publishing
- 1.7. Global Market: CAGR Calculation
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Trends and Outlook
- 3.3. Market Dynamics
- 3.4. Market Restraint Analysis
- 3.5. Business Environment Analysis
- 3.5.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
- 3.5.2. Porter's Five Forces Analysis
- 3.6. COVID-19 Impact Analysis
Chapter 4. Type Business Analysis
- 4.1. Peripheral Vascular Stents Market, By Type: Key Takeaways
- 4.2. Peripheral Vascular Stents Market: Type Movement & Market Share Analysis, 2022 & 2030
- 4.3. Drug Eluting Stents (DES)
- 4.3.1. Global Drug Eluting Stents (DES) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4. Bare Metal Stents (BMS)
- 4.4.1. Global Bare Metal Stents (BMS) Peripheral Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5. Bioabsorbable Stents
- 4.5.1. Global Bioabsorbable Stents Peripheral Vascular Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Mode of Delivery Business Analysis
- 5.1. Peripheral Vascular Stents Market, By Mode of Delivery: Key Takeaways
- 5.2. Peripheral Vascular Stents Market: Mode of Delivery Movement & Market Share Analysis, 2022 & 2030
- 5.3. Self-expanding Stents
- 5.3.1. Global Coronary Artery Bypass Grafting (CABG) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.3.2. Balloon-expandable Stents
- 5.3.2.1. Global Balloon-expandable Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Product Business Analysis
- 6.1. Peripheral Vascular Stents Market, By Product: Key Takeaways
- 6.2. Peripheral Vascular Stents Market: Product Movement & Market Share Analysis, 2022 & 2030
- 6.3. Iliac Artery Stents
- 6.3.1. Global Iliac Artery Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.2. Femoral Artery Stents
- 6.3.2.1. Global Femoral Artery Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.3. Carotid Artery Stents
- 6.3.3.1. Global Carotid Artery Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.4. Renal Artery Stents
- 6.3.4.1. Global Renal Artery Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.5. Other Peripheral Stents
- 6.3.5.1. Global Other Peripheral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. End-Use Business Analysis
- 7.1. Peripheral Vascular Stents Market, By End-Use: Key Takeaways
- 7.2. Peripheral Vascular Stents Market: End-Use Movement & Market Share Analysis, 2022 & 2030
- 7.3. Hospitals & Cardiac Centers
- 7.3.1. Global Hospitals & Cardiac Centers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4. Ambulatory Surgical Centers
- 7.4.1. Global Ambulatory Surgical Centers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5. Others
- 7.5.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Regional Business Analysis
- 8.1. Regional Market Snapshot
- 8.2. Market Share Analysis by Country, 2022
- 8.2.1. North America
- 8.2.2. Europe
- 8.2.3. Asia Pacific
- 8.2.4. Latin America
- 8.2.5. MEA
- 8.3. North America
- 8.3.1. North America Peripheral Vascular Stents Market, 2018 - 2030 (USD Million)
- 8.3.2. U.S.
- 8.3.2.1. U.S. Peripheral Vascular Stents Market, 2018-2030 (USD Million)
- 8.3.3. Canada
- 8.3.3.1. Canada Peripheral Vascular Stents Market, 2018 - 2030 (USD Million)
- 8.4. Europe
- 8.4.1. Europe Peripheral Vascular Stents Market, 2018 - 2030 (USD Million)
- 8.4.2. Germany
- 8.4.2.1. Germany Peripheral Vascular Stents Market, 2018 - 2030 (USD Million)
- 8.4.3. UK
- 8.4.3.1. UK Peripheral Vascular Stents Market, 2018 - 2030 (USD Million)
- 8.4.4. France
- 8.4.4.1. France Peripheral Vascular Stents Market, 2018 - 2030 (USD Million)
- 8.4.5. Italy
- 8.4.5.1. Italy Peripheral Vascular Stents Market, 2018 - 2030 (USD Million)
- 8.4.6. Spain
- 8.4.6.1. Spain Peripheral Vascular Stents Market, 2018 - 2030 (USD Million)
- 8.4.7. Denmark
- 8.4.7.1. Denmark Peripheral Vascular Stents Market, 2018 - 2030 (USD Million)
- 8.4.8. Sweden
- 8.4.8.1. Sweden Peripheral Vascular Stents Market, 2018 - 2030 (USD Million)
- 8.4.9. Norway
- 8.4.9.1. Norway Peripheral Vascular Stents Market, 2018 - 2030 (USD Million)
- 8.5. Asia Pacific
- 8.5.1. Asia Pacific Peripheral Vascular Stents Market, 2018 - 2030 (USD Million)
- 8.5.2. Japan
- 8.5.2.1. Japan Peripheral Vascular Stents Market, 2018 - 2030 (USD Million)
- 8.5.3. China
- 8.5.3.1. China Peripheral Vascular Stents Market, 2018 - 2030 (USD Million)
- 8.5.4. India
- 8.5.4.1. India Peripheral Vascular Stents Market, 2018 - 2030 (USD Million)
- 8.5.5. South Korea
- 8.5.5.1. South Korea Peripheral Vascular Stents Market, 2018 - 2030 (USD Million)
- 8.5.6. Australia
- 8.5.6.1. Australia Peripheral Vascular Stents Market, 2018 - 2030 (USD Million)
- 8.5.7. Thailand
- 8.5.7.1. Thailand Peripheral Vascular Stents Market, 2018 - 2030 (USD Million)
- 8.6. Latin America
- 8.6.1. Latin America Peripheral Vascular Stents Market, 2018 - 2030 (USD Million)
- 8.6.2. Brazil
- 8.6.2.1. Brazil Peripheral Vascular Stents Market, 2018 - 2030 (USD Million)
- 8.6.3. Mexico
- 8.6.3.1. Mexico Peripheral Vascular Stents Market, 2018 - 2030 (USD Million)
- 8.6.4. Argentina
- 8.6.4.1. Argentina Peripheral Vascular Stents Market, 2018 - 2030 (USD Million)
- 8.7. MEA
- 8.7.1. MEA Peripheral Vascular Stents Market, 2018 - 2030 (USD Million)
- 8.7.2. South Africa
- 8.7.2.1. South Africa Peripheral Vascular Stents Market, 2018 - 2030 (USD Million)
- 8.7.3. Saudi Arabia
- 8.7.3.1. Saudi Arabia Peripheral Vascular Stents Market, 2018 - 2030 (USD Million)
- 8.7.4. UAE
- 8.7.4.1. UAE Peripheral Vascular Stents Market, 2018 - 2030 (USD Million)
- 8.7.5. Kuwait
- 8.7.5.1. Kuwait Peripheral Vascular Stents Market, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Company Categorization
- 9.2. Strategy Mapping
- 9.3. Company Profiles/Listing
- 9.3.1. Medtronic
- 9.3.1.1. Overview
- 9.3.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.1.3. Product Benchmarking
- 9.3.1.4. Strategic Initiatives
- 9.3.2. Terumo Europe NV
- 9.3.2.1. Overview
- 9.3.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.2.3. Product Benchmarking
- 9.3.2.4. Strategic Initiatives
- 9.3.3. Boston Scientific Inc.
- 9.3.3.1. Overview
- 9.3.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.3.3. Product Benchmarking
- 9.3.3.4. Strategic Initiatives
- 9.3.4. Stryker
- 9.3.4.1. Overview
- 9.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.4.3. Product Benchmarking
- 9.3.4.4. Strategic Initiatives
- 9.3.5. Biotronik
- 9.3.5.1. Overview
- 9.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.5.3. Product Benchmarking
- 9.3.5.4. Strategic Initiatives
- 9.3.6. Cook Medical
- 9.3.6.1. Overview
- 9.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.6.3. Product Benchmarking
- 9.3.6.4. Strategic Initiatives
- 9.3.7. Microport Scientific Corporation
- 9.3.7.1. Overview
- 9.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.7.3. Product Benchmarking
- 9.3.7.4. Strategic Initiatives
- 9.3.8. Lifetech
- 9.3.8.1. Company Overview
- 9.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.8.3. Platform Benchmarking
- 9.3.8.4. Strategic Initiatives
- 9.3.9. iVascular SLU
- 9.3.9.1. Company Overview
- 9.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.9.3. Platform Benchmarking
- 9.3.9.4. Strategic Initiatives
- 9.3.10. Hellman & Friedman (Cordis Inc.)
- 9.3.10.1. Company Overview
- 9.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.10.3. Platform Benchmarking
- 9.3.10.4. Strategic Initiatives
- 9.3.11. Stentys S.A.
- 9.3.11.1. Company Overview
- 9.3.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
- 9.3.11.3. Platform Benchmarking
- 9.3.11.4. Strategic Initiatives